GTF2H2 (General Transcription Factor IIH Subunit 2) encodes a core component of the TFIIH complex, a multifunctional protein complex essential for both transcription initiation by RNA polymerase II and nucleotide excision repair (NER) of bulky DNA lesions. GTF2H2, together with GTF2H3 and GTF2H4, forms the XPB helicase subunit that provides the ATP-dependent helicase activity required for DNA unwinding during NER and promoter opening during transcription initiation[1].
The TFIIH complex is unique among general transcription factors in having a direct role in DNA repair, making it particularly important for neurons that face high rates of DNA damage from oxidative metabolism and environmental stressors. Mutations in TFIIH subunits, including GTF2H2, cause severe neurological disorders including xeroderma pigmentosum (XP) and Cockayne syndrome (CS), underscoring the critical link between TFIIH function and neuronal survival[2].
| Property | Value |
|---|---|
| Gene Symbol | GTF2H2 |
| Chromosomal Location | 5q13.2 |
| NCBI Gene ID | 2966 |
| UniProt ID | Q13887 |
| Protein Length | 395 amino acids |
| Molecular Weight | ~44 kDa |
| Protein Class | General transcription factor, DNA repair protein |
| Aliases | BTF2p44, TFB2, p44 |
| Expression | Ubiquitous; high in brain, testis, thymus |
GTF2H2 is a component of the XPB (ERCC3)-containing core TFIIH subcomplex. Together with GTF2H3 and GTF2H4, it forms the structural core that anchors and activates the XPB helicase. The XPB helicase (encoded by ERCC3/GTF2H2) translocates 3'→5' along DNA, providing the unwinding activity needed for both NER dual incision and transcription initiation.
The TFIIH complex (transcription factor II H) is a large multiprotein assembly of approximately 10 subunits organized into two subcomplexes:
Core TFIIH (6 subunits):
CAK subcomplex (cyclin-dependent kinase-activating kinase):
GTF2H2 interacts directly with XPB through its zinc finger domain, enhancing its ATPase and helicase activity by approximately 10-fold[1:1].
NER is the primary pathway for removing bulky, helix-distorting DNA lesions including:
The NER pathway proceeds through:
GTF2H2's XPB helicase activity is essential for the DNA unwinding step. Without functional XPB-GTF2H2, the NER machinery cannot open the DNA helix sufficiently for dual incision[3].
TFIIH is recruited to the pre-initiation complex (PIC) through interactions with RNA polymerase II and other general transcription factors. Its roles in transcription:
Beyond basal transcription, TFIIH participates in:
Neurons are particularly dependent on NER for several reasons:
Defects in NER, including GTF2H2 dysfunction, compromise neuronal genomic integrity and contribute to neurodegeneration[4].
Accumulated DNA damage: AD brains show elevated levels of oxidative DNA lesions (8-oxoguanine, CPDs) in vulnerable neurons of the hippocampus and cortex. Impaired NER capacity contributes to this accumulation[5].
TFIIH dysfunction in AD: Studies report reduced TFIIH levels and activity in AD brains, potentially from transcriptional downregulation or protein aggregation. Reduced TFIIH impairs both NER and transcription, creating a vicious cycle of genomic instability and impaired cellular maintenance[4:1].
Transcription dysregulation: TFIIH dysfunction contributes to the transcriptional downregulation observed in AD, including reduced expression of synaptic proteins, neurotrophic factors, and cellular maintenance genes.
Therapeutic strategies: Enhancing TFIIH function or NER capacity could help neurons cope with the elevated DNA damage load in AD. However, caution is needed as excessive NER could interfere with normal transcriptional programs.
Oxidative DNA damage in dopaminergic neurons: PD neurons in the substantia nigra pars compacta face chronic oxidative stress from mitochondrial dysfunction, auto-oxidation of dopamine, and environmental toxins. This generates bulky DNA lesions requiring NER for repair[6].
TFIIH and dopaminergic neuron survival: TFIIH activity is particularly important for neurons with high metabolic rates. Reduced NER capacity could accelerate the accumulation of DNA damage in dopaminergic neurons, contributing to their selective vulnerability in PD[7].
Alpha-synuclein interactions: Alpha-synuclein pathology may interfere with DNA repair machinery, including potentially TFIIH. Research suggests that alpha-synuclein aggregates can sequester DNA repair proteins, impairing their function.
These human diseases provide direct evidence of GTF2H2's importance for neuronal survival:
Xeroderma Pigmentosum (XP): Caused by mutations in NER genes including XPB (ERCC3). Patients develop:
Cockayne Syndrome (CS): Caused by mutations in CSA (ERCC8) and CSB (ERCC6), proteins involved in TC-NER. Features:
Overlapping XP/CS: Some patients have mutations in XPB or XPD that cause both XP and CS features, demonstrating that TFIIH mutations can produce severe neurodegeneration[8].
GTF2H2 forms a core structural unit with XPB and other TFIIH core subunits:
| Partner | Interaction Type | Functional Role |
|---|---|---|
| XPB (ERCC3) | Direct binding | Helicase activity, core stability |
| GTF2H3 | Heterodimerization | XPB stabilization |
| GTF2H4 | Heterodimerization | XPB stabilization |
| p52 (GTF2H1) | Protein interaction | Bridge to CAK |
| XPD (ERCC2) | Within complex | Regulatory helicase |
| RNA Pol II | Within PIC | Transcription initiation |
| XPA | NER recruitment | Lesion verification |
GTF2H2 activity is regulated by:
Approaches to boost NER capacity in neurons include:
Neuron-specific NER regulation: How is NER, including GTF2H2 function, specifically regulated in post-mitotic neurons vs. dividing cells?
TC-NER vs. GG-NER contribution: What is the relative importance of transcription-coupled vs. global genomic NER in neurodegeneration?
Cross-talk with transcription: How does GTF2H2's dual role in transcription and repair affect neuronal gene expression programs?
Therapeutic targeting: Can GTF2H2 or XPB activity be selectively enhanced for DNA repair without disrupting transcription?
Disease models: What are the best cellular and animal models for studying GTF2H2-related neurodegeneration?
Biomarkers: Could NER capacity or GTF2H2 activity levels serve as biomarkers for neurodegeneration risk?
Egly JM, Coin F. A history of TFIIH: thirty years of molecular biology for the repair of DNA lesions. DNA Repair. 2014. ↩︎ ↩︎
Schlei S, et al. TFIIH mutations and neurological disease phenotypes. Human Molecular Genetics. 2018. ↩︎
Mari PO, et al. Nucleotide excision repair in neurons and neurodegeneration. Trends in Neurosciences. 2019. ↩︎
Reinhart J, et al. TFIIH complex in neurodegeneration and neuronal DNA repair. Neurobiology of Aging. 2019. ↩︎ ↩︎
Krishnan V, et al. ATM and BER pathway defects in Alzheimer's disease. Journal of Neurochemistry. 2014. ↩︎
Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegeneration. Nature Reviews Neuroscience. 2006. ↩︎
Gervas CG, et al. DNA repair defects in dopaminergic neuron vulnerability. Neuroscience Letters. 2019. ↩︎
Kim J, et al. TFIIH and Cockayne syndrome: connecting transcription to DNA repair. EMBO Journal. 2015. ↩︎
Iyama T, Wilson DM 3rd. DNA repair mechanisms in neurons. Free Radical Biology and Medicine. 2013. ↩︎
Jacobson MK, et al. DNA repair and neurodegeneration: a TFIIH perspective. Neurochemical Research. 2014. ↩︎